EDIT vs UAL · rev $32.3M vs P/E 10, rev $57.06B
Editas Medicine Inc (EDIT) versus United Airlines Holdings Inc (UAL) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
United Airlines Holdings Inc (UAL) is a airlines company listed on NASDAQ. It is led by Scott Kirby.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported UAL revenue for 2024-12-31 was $57.06B. Net income was $3.15B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
EDIT currently screens at market cap $375.2M. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
Not investment advice. Open the EDIT and UAL stock pages for the full models.
Not investment advice.